A share price of Hims & Hers Health Inc [HIMS] is currently trading at $12.55, up 0.40%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have gain 5.64% over the last week, with a monthly amount drifted -18.88%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on April 16, 2024, when Jefferies downgraded its rating to a Hold and also revised its price target to $15 from $17. Previously, Canaccord Genuity started tracking the stock with Buy rating on April 10, 2024, and set its price target to $20. On February 28, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $16 on the stock. Leerink Partners started tracking the stock assigning a Market Perform rating and suggested a price target of $10 on February 26, 2024. Imperial Capital initiated its recommendation with a In-line and recommended $9 as its price target on December 07, 2023. TD Cowen started tracking with a Outperform rating for this stock on July 28, 2023, and assigned it a price target of $11. In a note dated April 11, 2023, Robert W. Baird initiated an Neutral rating and provided a target price of $10 on this stock.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $5.65 and $17.16. Currently, Wall Street analysts expect the stock to reach $10.8 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $12.55 at the most recent close of the market. An investor can expect a potential drop of -13.94% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 872.00M which represents 47.50% growth. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.07 and Total Capital is -0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.38 points at the first support level, and at 12.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.77, and for the 2nd resistance point, it is at 12.99.
Hims & Hers Health Inc [HIMS] reported earnings per share of $0.01 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.02/share, meaning a difference of $0.03 and a surprise factor of 150.00%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.04 per share as compared to estimates of -$0.03 per share, a difference of -$0.01 representing a surprise of -33.30%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 3.00. As well, the Quick Ratio is 2.74, while the Cash Ratio is 1.09. Considering the valuation of this stock, the price to sales ratio is 3.08, the price to book ratio is 7.79.
Transactions by insiders
Recent insider trading involved Boughton Soleil, Chief Legal Officer, that happened on Apr 15 ’24 when 2503.0 shares were sold. Chief Operating Officer, Baird Melissa completed a deal on Apr 08 ’24 to sell 11751.0 shares. Meanwhile, Chief Operating Officer Baird Melissa sold 11751.0 shares on Apr 05 ’24.
